• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
  • Contact

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

7 In 10 Massachusetts Residents Believe Narcan Should Be Made Widely Available In Workplaces, According To New Poll Released By Blue Cross Blue Shield Of Massachusetts

State's largest insurer launches first opioid toolkit for employers to help prevent lethal overdoses

Blue Cross Blue Shield of Massachusetts

News provided by

Blue Cross Blue Shield of Massachusetts

Oct 04, 2018, 06:03 ET

Share this article

Share this article


BOSTON, Oct. 4, 2018 /PRNewswire/ -- Seventy percent of Massachusetts residents believe the opioid-reversal drug commonly known as Narcan should be widely available in workplaces, similar to automated external defibrillators (AEDs). The finding is part of a new opinion poll just released by Blue Cross Blue Shield of Massachusetts ("Blue Cross"). The poll was conducted in September 2018 by Anderson-Robbins Research and comprises a representative sample of Massachusetts residents.

Continue Reading
The kits, designed to be kept in the workplace, contain two doses of Narcan nasal spray, a surgical mask and gloves, and instructions on administering Narcan.
The kits, designed to be kept in the workplace, contain two doses of Narcan nasal spray, a surgical mask and gloves, and instructions on administering Narcan.
Blue Cross Blue Shield of Massachusetts puts opioid toolkits in workplaces to help stop lethal overdoses
Blue Cross Blue Shield of Massachusetts puts opioid toolkits in workplaces to help stop lethal overdoses

In conjunction with this finding, Blue Cross today becomes the first health plan in the state to provide opioid toolkits for employer customers. The kits, designed to be kept in the workplace, contain two doses of Narcan nasal spray, a surgical mask and gloves, and instructions on administering Narcan. Along with the kits, Blue Cross will provide onsite employee education and Narcan training, and an online opioid resource center, with information on family support, medication safety, pain management and opioid use disorder treatment care options, including information on how to access medication-assisted treatment.

"The opioid crisis has grown to be one of the most devastating public health epidemics we've faced as a nation," said Andrew Dreyfus, president & CEO at Blue Cross. "So Blue Cross is teaming up with employers as part of our response to the crisis. We're providing them with the resources they need to reverse overdoses and educate their employees, whether in an office setting, a job site or a city hall."

Four Blue Cross customers are participating in a pilot program to test the effectiveness of the toolkits, training, and online resource center. They include Shawmut Construction, New England Regional Council of Carpenters, the city of Brockton, and the town of Ware. Blue Cross is also introducing the toolkits and training into its own workplaces.

"We tested the toolkit idea with consumers, half of whom had a personal experience with opioid addiction via family members or friends," said Dr. Ken Duckworth, Blue Cross' medical director for behavioral health. "Their feedback helped inform what we included in the kits and what type of education and information we'll provide along with the supplies. We know there's not a single solution to this epidemic, but this is an important step toward empowering employees to be leaders when it comes to this crisis."

"Working in an industry that's the second-most susceptible to opioid abuse, we've created a cross-functional opioid task force to develop educational tools and resources for our employees and partners," said Shaun Carvalho, safety director at Shawmut Design and Construction. "So when Blue Cross approached us about piloting the employer opioid toolkit, we saw it as the perfect opportunity to enhance our efforts, starting at the office level and working with the team to eventually get the toolkits to all of our jobsites."

"The city of Brockton has been a leader in the fight against opioid overdose deaths," said Brockton Mayor Bill Carpenter. "We're on the front lines of this public health crisis and we're committed to providing the education and training needed to help stem this epidemic. These toolkits, along with the additional resources Blue Cross is providing, will be an important resource as we continue to raise awareness about prevention and intervention, and equip more members of the community to be able to respond in the event of an overdose."

Since 2012, with the introduction of its Prescription Pain Medication Safety Program, Blue Cross has been a leader in Massachusetts and nationwide in helping to stem the opioid epidemic through a variety of innovative efforts focusing on education, prevention, treatment, and recovery. Blue Cross is a founding member of RIZE Massachusetts, which seeks to build a $50 million fund focused on bringing real and lasting change to those struggling with substance use disorders in the Commonwealth. In 2018, Blue Cross made a quarter-million-dollar investment in an innovative, peer-to-peer opioids education program called Drug Story Theater.  Additionally, Blue Cross has removed co-pays for Narcan for most of our fully insured plan designs.

Full survey results can be found here. 

Methodology
Anderson-Robbins interviewed 507 Massachusetts adults as part of this poll. Interviews were conducted by trained professionals working from a central, monitored location between the dates of September 5-13, 2018. Telephone numbers were randomly selected using a random digit dial methodology and a probability proportionate to size approach, meaning numbers are proportionally representative to the number of adults in each region of the state. Respondents were contacted on both landlines and cellphones. The overall results have a margin of error of ±4.0%; the margin of error within individual subgroups is higher.

About Blue Cross Blue Shield of Massachusetts
Blue Cross Blue Shield of Massachusetts (bluecrossma.com) is a community-focused, tax-paying, not-for-profit health plan headquartered in Boston. We're the trusted health plan for more than 25,000 Massachusetts employers and are committed to working with others in a spirit of shared responsibility to make quality health care affordable. Consistent with our corporate promise to always put our 2.8 million members first, we're rated among the nation's best health plans for member satisfaction and quality. Connect with us on Facebook, Twitter, YouTube, and LinkedIn.

SOURCE Blue Cross Blue Shield of Massachusetts

Related Links

http://www.bluecrossma.com

Modal title

Also from this source

BLUE CROSS BLUE SHIELD OF MASSACHUSETTS EXPEDITES ACCESS TO CARE FOR TEXAS MEMBERS AFFECTED BY SEVERE WEATHER

BLUE CROSS BLUE SHIELD OF MASSACHUSETTS EXPEDITES ACCESS TO CARE FOR TEXAS MEMBERS AFFECTED BY SEVERE WEATHER


BLUE CROSS BLUE SHIELD OF MASSACHUSETTS EXPEDITES ACCESS TO CARE FOR ALABAMA AND GEORGIA MEMBERS AFFECTED BY SEVERE WEATHER

BLUE CROSS BLUE SHIELD OF MASSACHUSETTS EXPEDITES ACCESS TO CARE FOR ALABAMA AND GEORGIA MEMBERS AFFECTED BY SEVERE WEATHER

Explore

More news releases in similar topics

  • Health Care & Hospitals
  • Mental Health
  • Medical Pharmaceuticals
  • Pharmaceuticals
  • Health Insurance

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2023 Cision US Inc.